Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer-Reference-Cited by-同舟云学术

Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Published:2020-02 Issue:2 Volume:271 Page:245-256
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Eyck Ben M.,Onstenk Barbera D.,Noordman Bo J.,Nieboer Daan,Spaander Manon C. W.,Valkema Roelf,Lagarde Sjoerd M.,Wijnhoven Bas P. L.,van Lanschot J. Jan B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference93 articles.

1. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

2. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial;Yang;J Clin Oncol,2018

3. Long-term health-related quality of life following surgery for oesophageal cancer;Djarv;Br J Surg,2008

4. Effect of neoadjuvant chemoradiotherapy on health-related quality of life in esophageal or junctional cancer: results from the randomized CROSS trial;Noordman;J Clin Oncol,2018

5. Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial;Noordman;BMC Cancer,2018

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MR-linac based radiation therapy in gastrointestinal cancers: a narrative review;Journal of Gastrointestinal Oncology;2024-08

2. Integrating MR radiomics and dynamic hematological factors predicts pathological response to neoadjuvant chemoradiotherapy in esophageal cancer;Heliyon;2024-07

3. Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative);European Journal of Surgical Oncology;2024-07

4. Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma;International Journal of Molecular Sciences;2024-05-31

5. Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial;Radiotherapy and Oncology;2024-05